Neurogene launches public stock offering
Seeking Alpha ·
Neurogene ( NGNE ) commenced a public offering of common stock, with certain investors able to purchase pre-funded warrants instead of shares. The company expects to grant underwriters a 30-day option to purchase additional shares. All securities are being offered by Neurogene.
DYAX Investor Sentiment
Bullish (Long) 49% · Bearish (Short) 51%
368 participants
Related News
- NASA awards $600M in new lunar missions, lifting Intuitive Machines, Firefly, Astrobotic
- Greenbrier Q3 2026 Earnings Preview
- UniFirst Q3 2026 Earnings Preview
- FactSet Research Systems Q3 2026 Earnings Preview
- Lockheed Martin lands $3B U.S. Army Sentinel A4 radar production deal
- Oceaneering prices tender offer for 2028 Senior Notes